A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis
- Ages
- 18 Years - 80 Years
- Sexes
- All
Clinical trials
-
XTMAB -
Sapphire This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.
- Investigator
- Ali Ataya
- Ages
- 18 Years - 99 Years
- Sexes
- All